A Study of RO7296682 in Patients with Advanced Solid Tumours

Trial ID: NCT04158583
Kidney Cancer Type: Any


RO7296682 is an experimental cancer therapy. RO7296682 is a placeholder name used until the completion of the clinical trial.

The Trial:

This study will investigate the safety and effectiveness of RO7296682 for treating advanced kidney cancer.

Different doses of RO7296682 will be used to determine the dosage with the greatest benefit and fewest side effects.

Basic Eligibility:

  • Cancer has spread or cannot be removed by surgery
  • Must have received at least one other treatment for kidney cancer
  • No previous treatment with immunotherapy

Additional eligibility criteria will apply. Please speak to your doctor.


Find out more about this study.
Hospital / Cancer CentrePrincipal InvestigatorLocationTrial Status
Hospital / Cancer CentreBC Cancer Agency - Vancouver Principal Investigator LocationVancouver, British Columbia Trial StatusNot yet recruiting
Hospital / Cancer CentreThe Ottawa Hospital Cancer Centre Principal Investigator LocationOttawa, Ontario Trial StatusNot yet recruiting
Hospital / Cancer CentrePrincess Margaret Cancer Centre Principal Investigator LocationToronto, Ontario Trial StatusNot yet recruiting
Do NOT follow this link or you will be banned from the site!